Figure 2From: The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseasesFrequency distribution of physical component summary scores. Frequency distribution of baseline physical component summary scores (PCS) for patients with rheumatoid arthritis (RA) (a), psoriatic arthritis (PsA) (b), and ankylosing spondylitis (AS) (c) in infliximab clinical trials.Back to article page